Navigation Links
Medicinal chemist wins inaugural De Burgh Fellowship
Date:11/11/2010

Medicinal chemist Dr Guillaume Lessene has been awarded the Walter and Eliza Hall Institute's inaugural de Burgh Fellowship at the institute's annual general meeting in Melbourne, Australia.

The $AUD150,000 de Burgh Fellowship honours the role Professor Patrick de Burgh played in shaping the Walter and Eliza Hall Institute. It was established this year following the death of Professor de Burgh in August at the age of 94.

It was in Professor de Burgh's laboratory at the University of Sydney that institute legends Professor Donald Metcalf, Professor Jacques Miller and Sir Gustav Nossal obtained their first taste of research.

Professor de Burgh was a Bosch Professor or Bacteriology at the University of Sydney and worked on the pathogenesis of infectious disease.

Dr Lessene said it was a great honour to be named the de Burgh Fellow. "The fact the fellowship acknowledges translational research is really important that is what I do every day and it's great that these activities are supported by the fellowship and the institute," Dr Lessene said.

Dr Lessene translates research findings from the institute into the discovery and development of new drugs. His main focus is cancer research and Dr Lessene is currently working on developing inhibitors to the pro-survival Bcl-2 proteins that are involved in programmed cell death, for treatment of several types of cancer. He is also involved in projects looking at other cancer targets, such as tyrosine kinases, and non-cancer targets involved in conditions such as Alzheimer's disease.

"We work in multidisciplinary teams in constant interaction with biologists to create small molecules that will interact with or modulate recognised cell signaling pathways or targets involved in disease, with the aim of treating or curing that disease," Dr Lessene said.

"The very high standing of the research at the institute is a key element in the success of our program. The Chemical Biology division of which I am part is there to take the next step, bringing these biological discoveries from the laboratory and translating them into molecules that have the right biological activities and properties to reach clinical trials and potentially become a new drug."

Institute director Professor Doug Hilton congratulated Dr Lessene and said the institute and the Australian community owed Professor de Burgh a great debt.

"One could only imagine the shape of Australian medical research today had Professor de Burgh provided a humdrum rather than an inspiring environment," Professor Hilton said.

"The De Burgh Fellowship is awarded to a scientist with an outstanding record of research or research translation, who collaborates productively with other members of the faculty, and who is likely to make a major contribution to the institute in the long term. Guillaume meets all these criteria with aplomb."


'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Related medicine news :

1. Medicinal cannabis review highlights dilemmas facing health care professionals
2. Pfizer joins open-access medicinal chemistry public-private collaboration
3. St. Johns wort collection mined for its medicinal value
4. MIT chemists engineer plants to produce new drugs
5. 2010 Chemistry Nobel laureate Ei-ichi Negishi leads C&EN webinar
6. Biochemist studies DNA repair with $787,000 in grants
7. MIT moves toward greener chemistry
8. Basque researchers apply chemistry to restoration of paintings and dating of signatures
9. Subtyping breast cancer by immunohistochemistry to investigate survival terms
10. Tastier MRE: Chemistry gives battlefield chow a gourmet flare
11. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medicinal chemist wins inaugural De Burgh Fellowship
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand ... Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be ... Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology: